Simplex Trading’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$296K Buy
21,500
+8,900
+71% +$134K ﹤0.01% 3834
2025
Q4
$227K Buy
12,600
+1,200
+11% +$21.5K ﹤0.01% 4098
2025
Q3
$211K Buy
11,400
+7,800
+217% +$123K ﹤0.01% 4878
2025
Q2
$57K Sell
3,600
-8,800
-71% -$157K ﹤0.01% 5786
2025
Q1
$240K Buy
12,400
+6,900
+125% +$145K ﹤0.01% 4129
2024
Q4
$121K Buy
5,500
+1,100
+25% +$21.2K ﹤0.01% 4999
2024
Q3
$74K Buy
4,400
+3,900
+780% +$57.9K ﹤0.01% 5513
2024
Q2
$5K Buy
500
+400
+400% +$4.47K ﹤0.01% 7837
2024
Q1
$1K Buy
+100
New +$1.02K ﹤0.01% 8542
2023
Q4
Sell
-10,700
Closed -$81K 8885
2023
Q3
$81K Sell
10,700
-3,100
-22% -$23.3K ﹤0.01% 5302
2023
Q2
$99K Buy
13,800
+600
+5% +$3.5K ﹤0.01% 5087
2023
Q1
$80K Sell
13,200
-55,800
-81% -$302K ﹤0.01% 5410
2022
Q4
$300K Sell
69,000
-1,800
-3% -$8.04K ﹤0.01% 3740
2022
Q3
$277K Buy
70,800
+1,100
+2% +$5.51K ﹤0.01% 4182
2022
Q2
$355K Buy
69,700
+68,700
+6,870% +$357K ﹤0.01% 3877
2022
Q1
$6K Buy
1,000
+500
+100% +$3.31K ﹤0.01% 9265
2021
Q4
$4K Buy
+500
New +$4.71K ﹤0.01% 9646

Other funds holding CLBT

Simplex Trading's CLBT Position: Q1 2026 in Review

Simplex Trading reduced its Cellebrite (CLBT) stake by 59% in Q1 2026, selling an estimated $374K and leaving 17,035 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #4112.

Simplex Trading first reported a position in CLBT in Q4 2021 and has held it in 17 quarters since. The position peaked at $927K in Q3 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Simplex Trading held 17,035 shares of Cellebrite worth $235K as of Q1 2026.
  • Simplex Trading sold 24,786 Cellebrite shares in Q1 2026, an estimated $374K.
  • Cellebrite made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4112 holding.
  • Simplex Trading first reported a position in Cellebrite in Q4 2021 and has held it in 17 quarters since.
  • Simplex Trading's Cellebrite position peaked at $927K in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.